Research and Development – Autumn Statment Update

Research and Development - Autumn Statment Update

Date:

Category:

Share this article:

The new Chancellor Jeremy Hunt delivered his Autumn Statement on Thursday 17th November with a number of key legislation changes.

After reports of abuse and fraud with the R&D SME scheme, the Chancellor announced a cut in the enhancement rate from 130% to 86% and the tax credit rate is being reduced from 14.5 % to 10%.

With regards to the RDEC scheme, this will increase from 13% to 20%.

The Government is still committed to encouraging R&D and is reviewing the system in order to simplify the process. They’ll also be looking at expanding the qualifying expenditure to include data and cloud costs and refocusing the support towards innovation in the UK.

The changes are due to take place from April 2023 which will give businesses some time to plan

With HMRC focusing on tackling fraud it’s vital that you ensure you are discussing your claim with an expert to ensure you’re compliant and maximising the amount you can claim.

Jon Goodier, Director said “The decision to cut R&D tax credit for SMEs is really frustrating, but with the qualifying expenditure expansion planned for April 2023, this should help partly mitigate the reduction of the enhancement rate.  We’ll of course continue to work closely with clients to maximise their claims by identifying all relevant and eligible costs related to their R&D activities”

R&D tax credits can be a bit of a minefield, so to ensure you are maximising the amount of R&D tax credit that you can claim, it’s worth discussing your claim with an expert. 

Speak to an R&D expert today

This website uses cookies

With these cookies, we and third parties can collect information about you and your internet behaviour, both within and outside our website. Based on this, we and third parties adjust the website, our communication, and advertisements to your interests and profile. You can read more information in our cookie statement.

If you opt for acceptance, we will place all cookies. If you opt for rejection, we will only place functional and analytical cookies. You can adjust your preferences at a later time.

Accept Reject More options

This website uses cookies

With these cookies, we and third parties can collect information about you and your internet behaviour, both within and outside our website. Based on this, we and third parties adjust the website, our communication, and advertisements to your interests and profile. You can read more information in our cookie statement.

Functional cookies
Arrow down

Functional cookies are essential for the proper functioning of our website. They allow us to enable basic functions such as page navigation and access to secure areas. These cookies do not collect personal information and cannot be disabled.

Analytical cookies
Arrow down

Analytical cookies help us gain insight into how visitors use our website. We collect anonymised data about page interactions and navigation, enabling us to continuously improve our site.

Marketing cookies
Arrow down

Marketing cookies are used to track visitors when they visit different websites. The goal is to display relevant advertisements to the individual user. By allowing these cookies, you help us show you relevant content and offers.

Accept all Save

Name

Subtitle
Developer
Location
They are focussed on creating a future-focused and relationship-driven culture, that keeps its promises to you, our team members, and partners.
Xeinadin